Bristol Discontinues Serzone, Stadol And 15 Other Brands; Safety In Numbers?
Executive Summary
Bristol will cease distribution of the antidepressant Serzone (nefazodone) effective June 14
You may also be interested in...
Roxro Files Rapid-acting Nasal Pain Spray
Specialty pharma reinvents generic ketorolac as hospital-strength pain med for short-term use at home.
Serzone Labeling Change Suggests Second-Line Use; Generics Affected
Labeling for generic versions of Bristol-Myers Squibb's Serzone will encourage second-line use due to an increased risk of hepatotoxicity with the antidepressant
Serzone Labeling Change Suggests Second-Line Use; Generics Affected
Labeling for generic versions of Bristol-Myers Squibb's Serzone will encourage second-line use due to an increased risk of hepatotoxicity with the antidepressant